Site icon Forkast

Acoer’s Jim Nasr on using blockchain to track Covid vaccinations

Jim Nasr

Welcome to Forkast Forecasts 2021. In this series, leaders, innovators and other visionaries in crypto and blockchain-related fields tell Forkast.News what they see as the most noteworthy industry developments over the past 12 months and their predictions for the new year.

Jim Nasr

Jim Nasr is the founder and CEO of Acoer, an Atlanta-based blockchain-enabled applications developer with a focus on healthcare.

Last year, Acoer employed Hedera Hashgraph‘s distributed ledger technology (DLT) to create a coronavirus-tracking application

“If you are using blockchain and using it correctly as we are, you can show that [healthcare] data provenance, and it can be interrogated by anybody on demand. What it doesn’t guarantee and really nobody can guarantee this is that the point of origin data collection is accurate,” Nasr told Forkast.News in a previous interview.

Hedera Hashgraph has recently been adopted for the cold chain monitoring of Covid-19 vaccines for the U.K.’s National Health Service hospitals, according to a statement from Hedera Hashgraph

See related article: How healthcare uses blockchain to wage a smarter war against the coronavirus pandemic

Prior to Acoer, Nasr was drug development services firm Certara’s vice president of technology as well as the U.S. Centers for Disease Control and Prevention’s chief software architect. He was also co-founder and CEO of Armedia, a technology firm providing enterprise content management services.

Biggest developments in 2020

Predictions for 2021

See related article: Tokenized health care? How Hedera Hashgraph could improve data transparency in medicine

See related article: How DLT is fighting the information war in Syria and saving lives

Exit mobile version